Topic: Alzheimer's Disease
French researchers said Tuesday they had found a promising new target in the fight against Alzheimer's, the debilitating brain disease that causes irreversible memory loss and dementia. In laboratory experiments, a team led by Etienne-Emile Beaulieu of the French National Institute of Health and Medical Research (INSERM) uncovered what could prove a critically important interaction between two types of ...
If the cardiologist's warnings don't scare you, consider this: Controlling blood pressure just might be the best protection yet known against dementia. In a flurry of new research, scientists scanned people's brains to show hypertension fuels a kind of scarring linked to later ...
Dimebon, or Dimebolin Hydrochloride, is an alternative medication for Alzheimer?s disease. It originated in Russia as an antihistamine for allergies and hayfever. It has been sold in Russia over-the-counter but after several antihistamines were introduced to the market, thus, it became less popular.
Dimebon is not the latest drug for Alzheimer's disease. Russians have been using the drug ...
What Is Alzheimer's disease?
Alzheimer's disease (AD) is an irreversible disease of the brain that affects somebody memory and additional abilities.
How Common Is Alzheimer's disease?
Alzheimer's disease is the common form of dementia in people age sixty-five and over. Across 5.2 million Americans are approximated to have Alzheimer's disease. By 2050 this number ...
